Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioequivalence of LEZIGA vs Trajenta (linagliptin 5 mg) in healthy Thai volunteers under fasting
TCTR20221031003Phase 0Completed
- Sponsor
- MacroPhar
- Start
- Apr 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 0, randomised, open-label trial of linagliptin (2 arms), sponsored by MacroPhar. Started Apr 2023; status: completed.
02
Drugs
linagliptin
Beyond the preview
Go deeper on TCTR20221031003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on TCTR20221031003.